Latest Articles
This New Vaccine Blocked Cancer In Mice. Here's Why Experts Say This Is A Major Breakthrough - Women's Health
This New Vaccine Blocked Cancer In Mice. Here's Why Experts Say This Is A Major Breakthrough Women's Health
Published: Oct. 15, 2025, 11 a.m.
B.C. researchers lead AI breakthrough in endometrial cancer identification - CTV News
B.C. researchers lead AI breakthrough in endometrial cancer identification CTV News
Published: Sept. 26, 2025, 1:44 a.m.
‘Huge’ breakthrough for ‘incurable’ disease - News.com.au
‘Huge’ breakthrough for ‘incurable’ disease News.com.au
Published: Sept. 25, 2025, 1:30 p.m.
‘Huge’ breakthrough for ‘incurable’ disease - news.com.au
‘Huge’ breakthrough for ‘incurable’ disease news.com.au
Published: Sept. 25, 2025, 1:30 p.m.
Spotlighting Disease Prevention Efforts Alongside Treatment Breakthroughs Are Crucial for Endometrial Cancer Risk Reduction - OncLive
Spotlighting Disease Prevention Efforts Alongside Treatment Breakthroughs Are Crucial for Endometrial Cancer Risk Reduction OncLive
Published: Sept. 23, 2025, 8:09 p.m.
95% Success Rate: IceCure's Breakthrough Cryoablation System Proves Effective in Multiple Cancer Studies - Stock Titan
95% Success Rate: IceCure's Breakthrough Cryoablation System Proves Effective in Multiple Cancer Studies Stock Titan
Published: Sept. 22, 2025, 12:30 p.m.
Endometrial cancer drug Rina-S wins FDA's breakthrough therapy designation - Rare Cancer News
Endometrial cancer drug Rina-S wins FDA's breakthrough therapy designation Rare Cancer News
Published: Sept. 10, 2025, 12:49 p.m.
Genmab (CPSE:GMAB) Is Up 10.3% After FDA Breakthrough for Rina-S in Endometrial Cancer – Has The Bull Case Changed? - Yahoo Finance
Genmab (CPSE:GMAB) Is Up 10.3% After FDA Breakthrough for Rina-S in Endometrial Cancer – Has The Bull Case Changed? Yahoo Finance
Published: Sept. 6, 2025, 11:31 a.m.
Pain Scores Drop from 8/10 to Zero: IceCure's ProSense Shows Breakthrough Results in Endometriosis Treatment - Stock Titan
Pain Scores Drop from 8/10 to Zero: IceCure's ProSense Shows Breakthrough Results in Endometriosis Treatment Stock Titan
Published: Sept. 4, 2025, 12:30 p.m.
Genmab shares rise 1.21% premarket after FDA grants Breakthrough Therapy Designation to Rina-S for endometrial cancer treatment. - AInvest
Genmab shares rise 1.21% premarket after FDA grants Breakthrough Therapy Designation to Rina-S for endometrial cancer treatment. AInvest
Published: Aug. 28, 2025, 8:24 a.m.
Link copied to clipboard!